Safety Efficacy and PK of Atazanavir/Ritonavir (300/100 mg qd) in HIV+ Pregnant Women Cohort
Background: Atazanavir/ritonavir (ATV/r) is one of the most popular protease inhibitor recommended to minimize the risk of mother to child transmission. The objectives of this study were to assess steady state ATV plasma concentrations at 24 hours post-dose (C24h) and the impact of several cofactors on its PK then to describe the efficacy of ATV/r…